We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured

Journal Scan / Research · October 14, 2020

Quality of Life Reported by Patients With Primary Metastatic Prostate Cancer Treated With ADT With and Without Concurrent Radiation Therapy

European Urology

 

Additional Info

Disclosure statements are available on the authors' profiles:

European Urology
Patient-Reported Quality of Life in Patients With Primary Metastatic Prostate Cancer Treated With Androgen Deprivation Therapy With and Without Concurrent Radiation Therapy to the Prostate in a Prospective Randomised Clinical Trial; Data From the HORRAD Trial
Eur Urol 2020 Sep 22;[EPub Ahead of Print], L Boevé, MCCM Hulshof, PCMS Verhagen, JWR Twisk, WPJ Witjes, P de Vries, RJA van Moorselaar, G van Andel, AN Vis

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Advanced Prostate Cancer Center of Excellence

Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.


Further Reading